Dear AsCNP Members:

This is our fourth AsCNP Presidential Correspondence. Our previous
correspondence can be found on our website:

6th AsCNP Congress
The 6th Asian Congress Neuropsychopharmacology (AsCNP) Congress was held in
Fukuoka, Japan, on October 11-13, 2019, together with the 49th Annual
Meeting of the Japanese Society of Neuropsychopharmacology (JSNP), 29th
Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology
(JSCNP), Fall Meeting of the Korean College of Neuropsychopharmacology
(KCNP), Fall Meeting of the Taiwanese Society of Biological Psychiatry and
Neuropsychopharmacology (TSBPN), and 2nd ASEAN-AsCNP Meeting
( The main theme of the AsCNP
2019 Congress was “Neuropsychopharmacology to the Next Generation: New Wave
from Asia.” Although Typhoon Hagibis descended on Japan during the
congress, the meeting concluded successfully with over 2,200 participants
(approximately 1,500 for AsCNP 2019). Among 85 oral sessions, including
Special Lectures and symposia and three poster sessions for the AsCNP 2019
congress, 84 oral sessions and three poster sessions were held (Photos 1-4).
On behalf of the AsCNP/JSNP/JSCNP 2019 Executive Committee, I would like to
express our sincere appreciation for your attendance and contributions to
the congress while overcoming many difficulties. The growing need for
central nervous system medications that are especially targeted to Asians
and recent advances in neuropsychopharmacology in both academia and industry
prompted many neuropsychopharmacologists, researchers, and clinicians in
related medical fields to participate in the congress from all over the

AsCNP Board Meeting
On October 12, the AsCNP Board Meeting was held in Fukuoka with 31 attendees
(Photo 5). The current status of AsCNP, which includes 3200 members from 17
countries/regions and has funds in the amount of JPY 8,000,000, was reported
by Atsumi Nitta (Japan), Secretary of AsCNP. She announced that the company
that assists with AsCNP management will be changed from Convention Linkage
to AE Planning on January 1, 2020. Shih-Ku Lin (Taiwan), Chair of the Award
Committee, reported the AsCNP Lundbeck Science Award. Andi J. Tanra
(Indonesia), Chair of the Education Committee, proposed the 3rd ASEAN-AsCNP
Meeting in Fall 2020. Gavin S. Dawe (Singapore), Chair of the 7th AsCNP
Congress in Singapore in 2021, discussed preparations for the congress and
mentioned fascinating aspects of Singapore (Photo 6). Our Korean AsCNP Board
Members preferred hosting the 10th AsCNP Congress in 2027 in Korea rather
than hosting the 8th AsCNP Congress in 2023. Tianmei Si and Zhong Chen,
Chinese AsCNP Board Members, agreed to consider hosting the 8th AsCNP
Congress in 2023.

AsCNP Lundbeck Science Award
The AsCNP Lundbeck Science Award was launched, with special thanks to
Lundbeck and our Award Committee for the generous support and hard work,
respectively. The awardees were Brian Dean (Australia) for basic research
and Toshiaki A. Furukawa (Japan) for clinical research. The award ceremony
and award lectures were held during the AsCNP 2019 Congress (Photos 7, 8).

The International College of Neuropsychopharmacology (CINP) is an important
partner of AsCNP. The CINP World Congress will be held in Taipei on June
25-28, 2020 ( (Photo 9). The CINP 2020 Committee
includes the Local Organizing Committee, South Asia and South-East Asia
Committee, and AsCNP Committee. Registration and the Call for Abstracts will
begin in November 2019. The Dragon Boat Festival will also occur during the
CINP congress in Taipei (
The CINP World Congress will be held in Tokyo on May 25-28, 2024. After
AsCNP 2019 in Fukuoka, CINP President Siegfried Kasper (Austria),
President-Elect Pierre Blier (Canada), Vice-President Shih-Ku Lin (Taiwan),
four CINP Councillors (Atsumi Nitta (Japan), Jun Soo Kwon (Korea), Ryota
Hashimoto (Japan), and Allan H. Young (United Kingdom)), and other
distinguished neuropsychopharmacologists visited Tokyo, and CINP decided
that Tokyo will be the host city for the CINP 2024 World Congress (Photo
Please mark your schedule.

I encourage you to visit the AsCNP website, which is frequently updated:

Kazutaka Ikeda
AsCNP President (2019, 2020)

October 2019
Kazutaka Ikeda, (Doctor of Medical Science)
Chair, Department of Psychiatry and Behavioral Sciences
Project Leader, Addictive Substance Project
Tokyo Metropolitan Institute of Medical Science
2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan
TEL: +81-3-6834-2379
FAX: +81-3-6834-2390
e-mail: [email protected]jp